The Europe Cell therapy market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027.
Market Introduction
Cell therapy, a medical intervention involving the introduction of viable cells into a patient—via injection, implantation, or grafting—holds significant promise. This technology hinges on the replacement of dysfunctional cells with healthy, operational ones. Stem cells are central to these advanced therapies due to their remarkable ability to differentiate into specific cell types required for the repair of damaged or defective tissues. Beyond this, cell therapy is instrumental in the evolution of regenerative medicine. The increasing occurrence of chronic diseases, the growing embrace of regenerative medicine, and a surge in approvals for cell-based therapies are all factors expected to drive substantial growth in the Cell therapy market during the projected period.
Download our Sample PDF Report
@ https://www.businessmarketinsights.com/sample/TIPRE00019052
Market Dynamics
The future expansion of the Cell therapy market is anticipated to be significantly influenced by factors such as the escalating prevalence of chronic diseases, the increasing acceptance of regenerative medicine approaches, and the growing number of regulatory approvals for cell-based treatments. However, a potential impediment to market growth is the considerable expense associated with cell therapy manufacturing, particularly in developing nations, throughout the forecast period.
The COVID-19 pandemic posed a considerable obstacle across the European landscape. The market for cell therapy instruments initially faced headwinds due to supply chain disruptions and a decline in demand stemming from widespread lockdowns across European countries. However, subsequent government support and initiatives led to a dramatic increase in the demand for cell therapy.
Market Scope
The European Cell therapy market’s scope is defined by several key dimensions: therapy type, product offerings, technological approaches, application areas, end-user segments, and geographical regions (countries). In terms of therapy types, the allogeneic segment dominated the market share in 2019, largely attributable to the significant availability of approved products for clinical application. Looking ahead, however, the autologous segment is expected to exhibit the most rapid compound annual growth rate within the market during the forecast period.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Europe Cell therapy market report are the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Alliance for Regenerative Medicine, National Institutes of Health, Anthony Nolan Foundation, among others.
EUROPE CELL THERAPY MARKET SEGMENTATION
Europe Cell Therapy Market: By Therapy Type
- Allogeneic
- Autologous
Europe Cell Therapy Market: By Product
- Consumables
- Equipment
- Systems and Software
Europe Cell Therapy Market: By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-Dimensional Technology
Europe Cell Therapy Market: By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
Europe Cell Therapy Market: By End User
- Research Institutes
- Hospitals
- Others
Europe Cell Therapy Market: By Country
- Germany
- France
- Italy
- UK
- Spain
Europe Cell Therapy Market: Company Profiles
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc.
- Mesoblast Limited
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
